PREVAIL THERAPEUTICS INC's ticker is PRVL and the CUSIP is 74140Y101. A total of 96 filers reported holding PREVAIL THERAPEUTICS INC in Q4 2020. The put-call ratio across all filers is 4.14 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2020 | $768,000 | +126.5% | 33,282 | 0.0% | 0.00% | – |
| Q3 2020 | $339,000 | -35.1% | 33,282 | -4.9% | 0.00% | – |
| Q2 2020 | $522,000 | +43.8% | 35,006 | +17.8% | 0.00% | – |
| Q1 2020 | $363,000 | +46.4% | 29,716 | +89.7% | 0.00% | – |
| Q4 2019 | $248,000 | +28.5% | 15,662 | 0.0% | 0.00% | – |
| Q3 2019 | $193,000 | – | 15,662 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|